Longer term holders than me (early 2019) may be able to enlighten me whatever became of the 2016 proposal to cross list on NASDAQ.
Obviously, getting human/canine trials running will cost big bucks. A further 10% dilution doesn't sit well with most holders.
Does anyone else think that re-visiting a NASDAQ listing could be a potential solution to funding trials now that the Elanco option is defunct?
I don't know the circumstances surrounding the 2016 attempt. Surely we are in a stronger position now. An IPO could raise sufficient capital to progress our trials as well as broaden our reputation.
Happy to hear any thoughts...
Good luck to all holders, Thrifty
- Forums
- ASX - By Stock
- PAA
- PharmAust - Now that is impressive
PharmAust - Now that is impressive, page-108
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.89M |
Open | High | Low | Value | Volume |
19.0¢ | 19.8¢ | 19.0¢ | $12.64K | 64.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 160525 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 261690 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 160525 | 0.190 |
8 | 219337 | 0.185 |
10 | 663129 | 0.180 |
9 | 481402 | 0.175 |
7 | 150016 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 261690 | 5 |
0.205 | 118006 | 6 |
0.210 | 333355 | 8 |
0.215 | 242995 | 6 |
0.220 | 669543 | 9 |
Last trade - 12.05pm 07/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
PAA (ASX) Chart |